Obesity Medicine 2026 - Updates in Obesity Medications (Recorded)

CME/CE Expiration Date: 4/12/29

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. 

Learning Objectives

  • Describe novel concepts in obesity pharmacotherapy emerging from recent research and clinical trials
  • Analyze new mechanisms of action underlying recently developed obesity medications and their implications for treatment selection
  • Evaluate how newer therapies may influence clinical practice, including patient outcomes, safety considerations, and integration into comprehensive care plans
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 0.75 Participation
Course opens: 
04/12/2026
Course expires: 
04/12/2029
Cost:
$18.75

Harold Bays, MD, MFOMA, FTOS, FACC, FNLA, FASPC, DABOM

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 0.75 Participation

Price

Cost:
$18.75
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to complete this course.